<!-- received="Wed Feb 26 19:16:26 1997 MDT" -->
<!-- sent="Wed, 26 Feb 1997 20:49:02 -0500 (EST)" -->
<!-- name="Enigl@aol.com" -->
<!-- email="Enigl@aol.com" -->
<!-- subject="Re: Human Cloning: The Trade-In Strategy" -->
<!-- id="3.0.1.32.19970227020059.00689dfc@glo.be" -->
<!-- inreplyto="Human Cloning: The Trade-In Strategy" -->
<title>extropians: Re: Human Cloning: The Trade-In Strategy</title>
<h1>Re: Human Cloning: The Trade-In Strategy</h1>
<i>Enigl@aol.com</i><br>
<i>Wed, 26 Feb 1997 20:49:02 -0500 (EST)</i>
<p>
<ul>
<li> <b>Messages sorted by:</b> <a href="date.html#2993">[ date ]</a><a href="index.html#2993">[ thread ]</a><a href="subject.html#2993">[ subject ]</a><a href="author.html#2993">[ author ]</a>
<!-- next="start" -->
<li> <b>Next message:</b> <a href="2994.html">RUDIHOFFMA@aol.com: "Re: MEDIA: Suggestions for Canadian TV: extropians &amp; cloning"</a>
<li> <b>Previous message:</b> <a href="2992.html">Enigl@aol.com: "Re: SCIFI: Linda Nagata's Latest Novel"</a>
<li> <b>Maybe in reply to:</b> <a href="2829.html">GBurch1@aol.com: "Human Cloning: The Trade-In Strategy"</a>
<!-- nextthread="start" -->
<li> <b>Next in thread:</b> <a href="3265.html">Julio R. Vaquer: "Re: Human Cloning: The Trade-In Strategy"</a>
<!-- reply="end" -->
</ul>
<hr>
<!-- body="start" -->
In a message dated 97-02-25 17:00:13 EST, you write: <br>
 <br>
&lt;&lt;  When we've got programmable <br>
 immune systems and programmable factories (the Drextech promise) life <br>
 will be spiffy. &gt;&gt; <br>
 <br>
Antibiotics have never "cured" any disease.  Antibiotics only slow disease<br>
progress so that our immune system has time to become programmed to fight the<br>
disease itself. <br>
 <br>
We already have programmable immune systems.  The speed of programming is the<br>
problem and that is where Drextech shows promise to me. <br>
 <br>
Davin <br>
 <br>
<p>
Davin C. Enigl, (Sole Proprietorship) MEAS<br>
President-Microbiologist<br>
<p>
Microbiology Consulting,  Hazard Analysis and <br>
Critical Control Points (HACCP), CGMP, and Validations<br>
for the Food, Cosmetic, Nutritional  Supplement, and Pharmaceutical Industry<br>
<p>
enigl@aol.com<br>
<a href="http://members.aol.com/enigl/index.html">http://members.aol.com/enigl/index.html</a><br>
<p>
February 26, 1997<br>
9:19 am<br>
<!-- body="end" -->
<hr>
<p>
<ul>
<!-- next="start" -->
<li> <b>Next message:</b> <a href="2994.html">RUDIHOFFMA@aol.com: "Re: MEDIA: Suggestions for Canadian TV: extropians &amp; cloning"</a>
<li> <b>Previous message:</b> <a href="2992.html">Enigl@aol.com: "Re: SCIFI: Linda Nagata's Latest Novel"</a>
<li> <b>Maybe in reply to:</b> <a href="2829.html">GBurch1@aol.com: "Human Cloning: The Trade-In Strategy"</a>
<!-- nextthread="start" -->
<li> <b>Next in thread:</b> <a href="3265.html">Julio R. Vaquer: "Re: Human Cloning: The Trade-In Strategy"</a>
<!-- reply="end" -->
</ul>
